gerd and glp-1 GLP-1s linked to higher risk in T2D patients: study | Phathom Pharmaceuticals posted on the topic GLP-1 receptor agonists | How
Description
The positive results were observed alongside weight loss and independently of it

Nat Commun (2022) 13:1057

Lilly has submitted orforglipron for approval in more than 40 countries

Digital PDF download
